(Q40141369)

17 September 2017

Post-exposure prophylaxis against Ebola virus disease with experimental antiviral agents: a case-series of health-care workers (English)

1 reference

17 September 2017

Ebola hemorrhagic fever

0 references

Orthoebolavirus zairense

0 references

health professional

1 reference

post-exposure prophylaxis

inferred from title

1 reference

6

1 reference

17 September 2017

10

Stephen Mepham

1 reference

17 September 2017

1

Michael Jacobs

1 reference

17 September 2017

Emma Aarons

2

1 reference

17 September 2017

Sanjay Bhagani

3

1 reference

17 September 2017

Ruaridh Buchanan

4

1 reference

17 September 2017

Ian Cropley

5

1 reference

17 September 2017

Rebecca Lester

7

1 reference

17 September 2017

Daniel Martin

8

1 reference

17 September 2017

Neal Marshall

9

1 reference

17 September 2017

Simon Warren

11

1 reference

17 September 2017

Alison Rodger

12

1 reference

17 September 2017

25 August 2015

1 reference

Lancet Infectious Diseases

17 September 2017

1 reference

17 September 2017

15

1 reference

17 September 2017

11

1 reference

17 September 2017

1300-1304

1 reference

Effective post-exposure treatment of Ebola infection

17 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900228-5

7 January 2021

Management of accidental exposure to Ebola virus in the biosafety level 4 laboratory, Hamburg, Germany

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900228-5

7 January 2021

Emergency postexposure vaccination with vesicular stomatitis virus-vectored Ebola vaccine after needlestick

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900228-5

7 January 2021

Risk of Misinterpretation of Ebola Virus PCR Results After rVSV ZEBOV-GP Vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900228-5

7 January 2021

Clinical recognition and management of patients exposed to biological warfare agents

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900228-5

7 January 2021

Post-exposure efficacy of oral T-705 (Favipiravir) against inhalational Ebola virus infection in a mouse model

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900228-5

7 January 2021

Successful treatment of advanced Ebola virus infection with T-705 (favipiravir) in a small animal model

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900228-5

7 January 2021

Favipiravir (T-705), a novel viral RNA polymerase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900228-5

7 January 2021

Dose regimen of favipiravir for Ebola virus disease

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900228-5

7 January 2021

West African Ebola epidemic after one year--slowing but not yet under control

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900228-5

7 January 2021

Ebola GP-specific monoclonal antibodies protect mice and guinea pigs from lethal Ebola virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900228-5

7 January 2021

Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900228-5

7 January 2021

Molecular characterization of the monoclonal antibodies composing ZMAb: a protective cocktail against Ebola virus

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900228-5

7 January 2021

Antibodies are necessary for rVSV/ZEBOV-GP-mediated protection against lethal Ebola virus challenge in nonhuman primates

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900228-5

7 January 2021

Mechanisms of immunity in post-exposure vaccination against Ebola virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900228-5

7 January 2021

Rapid diagnosis of Ebola hemorrhagic fever by reverse transcription-PCR in an outbreak setting and assessment of patient viral load as a predictor of outcome

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900228-5

7 January 2021

Chains of transmission and control of Ebola virus disease in Conakry, Guinea, in 2014: an observational study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900228-5

7 January 2021

10.1016/S1473-3099(15)00228-5

Identifiers

DOI

1 reference

17 September 2017

1 reference